Skip to main content
SpringerLink
Log in

Pharmacokinetics of continuous renal replacement therapy

  • Review Article
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Conclusion

The appropriate dosage adjustment of drugs during continuous extracorporeal renal replacement therapy requires an understanding of the clearance characteristics of the different techniques and knowledge of the pharmacokinetic parameters of the drugs. Extracorporeal drug removal can be calculated from these data. However, since pharmacokinetics are different in critically ill patients and in healthy volunteers, these calculations can only yield rough estimates and monitoring of drug level and/or clinical effect is still essential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bennett WN, Aronoff GR, Morrison G, Golper TA, Pulliam J, Wolfson M, Singer I (1983) Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis 3:155–193

    PubMed  Google Scholar 

  2. La Greca G, Biasoli S, Borin D, Brendolan A, Chiaramonte S, Fabris A, Feriani M, Pisani E, Ronco C (1983) Drugs and dialysis. Int J Artif Organs 6:139–156

    PubMed  Google Scholar 

  3. Lee CC, Marbury TC (1984) Drug therapy in patients undergoing hemodialysis: clinical pharmacokinetic considerations. Clin Pharmacokinet 9:42–66

    Google Scholar 

  4. Fillastre JP, Singlas E (1991) Pharmacokinetics of newer drugs in patients with renal impairment. I. Clin Pharmacokinet 20:293–310

    PubMed  Google Scholar 

  5. Singlas E, Fillastre JP (1991) Pharmacokinetics of newer drugs in patients with renal impairment. II. Clin Pharmacokinet 20:389–410

    PubMed  Google Scholar 

  6. St Peter WL, Redic-Kill KA, Halstenson CE (1992) Clinical pharmacokinetics of antibiotics in patients with impaired renal function. Clin Pharmacokinet 22:169–210

    PubMed  Google Scholar 

  7. Schetz M, Lauwers PM, Ferdinande P (1989) Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view. Intensive Care Med 15:349–357

    PubMed  Google Scholar 

  8. Reetze-Bonorden P, Bohler J, Keller E (1993) Drug dosage in patients during continuous renal replacement therapy: pharmacokinetic and therapeutic considerations. Clin Pharmacokinet 24:162–179

    Google Scholar 

  9. Cutler RE, Forland SC (1989) Changing drug dosage in renal insufficiency. 2. Dialysis of drugs. Dial Transplant 18:250–257

    Google Scholar 

  10. Rumpf KW, Rieger J, Ansorg R, Doht B, Scheler F (1977) Binding of antibiotics by dialysis membranes and its clinical relevance. Kidney Int 12:87

    Google Scholar 

  11. Kraft D, Lode H (197) Elimination of ampicillin and gentamicin by hemofiltration. Klin Wochenschr 57:195–196

    Google Scholar 

  12. Kronfol NO, Lau AH, Barakat MM (1987) Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration. ASAIO Trans 33:300–303

    PubMed  Google Scholar 

  13. Cigarran-Guldris S, Brier ME, Golper TA (1991) Tobramycin clearance during simulated continuous arteriovenous hemodialysis. Contrib Nephrol 93:120–123

    PubMed  Google Scholar 

  14. Vincent HH, Akçahuseyin E, Vos MC, Van Ittersum FJ, Van Duyl WA, Schalekamp MAD (1990) Determinants of blood flow and ultrafiltration in continuous arteriovenous hemodiafiltration: theoretical predictions and laboratory and clinical observations. Nephrol Dial Transplant 5:1031–1037

    PubMed  Google Scholar 

  15. Pallone TL, Petersen J (1988) Continuous arteriovenous hemofiltration: An in vitro simulation and mathematical model. Kidney Int 33:685–698

    PubMed  Google Scholar 

  16. Ronco C, Brendolan A, Borin D, Bragantini L, Fabris A, Feriani M, Chiaramonte S, La Greca G (1984) Permeability characteristics of polysulfone membranes in CAVH. In: Siebert HG, Mann H (eds) Continuous arteriovenous hemofiltration (CAVH). Karger, Basel, pp 59–63

    Google Scholar 

  17. Golper TA (1991) Drug removal during continous hemofiltration or dialysis. Contrib Nephrol 93:110–116

    PubMed  Google Scholar 

  18. Sprenger KGB, Stephan H, Kratz W, Huber K, Franz ME (1985) Optimising of hemodiafiltration with modern membranes? Contrib Nephrol 46:43–60

    PubMed  Google Scholar 

  19. Sigler MH, Teehan BP, Van Valckenburgh D (1987) Solute transport in continuous hemodialysis: a new treatment for acute renal failure. Kidney Int 32:562–571

    PubMed  Google Scholar 

  20. Davies SP, Kox WJ, Brown EA (1991) Clearance studies in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Contrib Nephrol 93:117–119

    PubMed  Google Scholar 

  21. Benet LZ, Williams RL (1992) Design and optimization of dosage regimens: pharmacokinetic data: In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. McGraw-Hill International New York, pp 1650–1735

    Google Scholar 

  22. Brater DG (1983) Pharmacokinetics. In: Chernow B (ed) The pharmacologic approach to the critically ill patient. Williams & Wilkins, Baltimore, pp 1–21

    Google Scholar 

  23. Blye E, Lorch J, Cortell S (1984) Extracorporeal therapy in the treatment of intoxication. Am J Kidney Dis 3:321–328

    PubMed  Google Scholar 

  24. Tillement JP, Lhoste F, Giudicelli JF (1978) Diseases and drug protein binding. Clin Pharmacokinet 3:144–154

    PubMed  Google Scholar 

  25. Wedlund PJ, Branch RA (1983) Adjustment of medications in liver failure. In: Chernow B (ed) The pharmacologic approach to the critically ill patient. Williams & Wilkins, Baltimore, pp 84–114

    Google Scholar 

  26. Elston AC, Bayliss MK, Park GR (1993) Effect of renal failure on drug metabolism by the liver. Br J Anaesth 71:282–290

    PubMed  Google Scholar 

  27. Bodenham A, Shelly NP, Park GR (1988) The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients. Clin Pharmacokinet 14:347–373

    PubMed  Google Scholar 

  28. Runciman WB, Myburgh JA, Upton RN (1990) Pharmacokinetics and pharmacodynamics in the critically ill. Baillieres Clin Anaesthesiol 4:271–303

    Google Scholar 

  29. Vos MC, Vincent HH, Yzerman EPF (1992) Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD). Intensive Care Med 18:282–285

    PubMed  Google Scholar 

  30. Lanese DM, Alfrey PS, Molitoris BA (1989) Markedly increased clearance of vancomycin during hemodialyses using polysulfone dialysers. Kidney Int 35:1409–1412

    PubMed  Google Scholar 

  31. Kong KL, Haynes S, Bion J (1990) Newer drugs in intensive care. Baillieres Clin Anaesthesiol 4:305–331

    Google Scholar 

  32. Feinfeld DA, Frishman WH (1987) Renal considerations in cardiovascular drug therapy. Cardiol Clin 5:675–688

    PubMed  Google Scholar 

  33. Verresen L, Waer M, Vanrenterghem Y, Michielsen P (1990) Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet 336:1360–1362

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care Medicine, UZ Gasthuisberg, Herestraat 49, B-3000, Leuven, Belgium

    M. Schetz, P. Ferdinande, G. Van den Berghe, C. Verwaest & P. Lauwers

Authors
  1. M. Schetz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Ferdinande
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Van den Berghe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Verwaest
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Lauwers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schetz, M., Ferdinande, P., Van den Berghe, G. et al. Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med 21, 612–620 (1995). https://doi.org/10.1007/BF01700172

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01700172

Keywords

Search

Navigation